Center for Clinical Tolerance
877-644-2860
The mission of the Center for Clinical Tolerance
This is the first center in the world dedicated to establishing clinical transplant tolerance as the standard of care in transplant surgery.
Transplant tolerance is an innovative method that enables the patient’s immune system to maintain the new organ without the need for long-term immunosuppressant medications, allowing for patients to reduce or even discontinue medication while still ensuring the success of the transplant. With transplant tolerance immunosuppression drug-free transplants are a possibility.
Frequently asked questions
To initiate tolerance after transplant surgery, the Legorreta Center for Clinical Transplant Tolerance at Mass General uses clinically tested treatments that combine donor bone marrow or blood stem cell transplantation with organ transplantation, which allows for the slow reduction of immunosuppressive medications after surgery. This is called simultaneous tolerance.
Our expert team infuses donor bone marrow or blood stem cells into the patient’s body at the same time as they transplant the organ. In the weeks following surgery, the cells expand and train the immune system to recognize the new organ and accept it as its own rather than attack it.
While immunosuppressive medications are still required immediately following surgery, they will be carefully and intentionally reduced over 9-18 months—sometimes, until no medication is needed at all.
We also aim to eliminate the need for lifelong immunosuppression in patients who underwent kidney transplant surgery in the past. Our preclinical studies have proven that this is possible, and we are currently enrolling patients into an FDA-approved clinical trial for “Delayed Tolerance.”
This approach is possible as long as the bone marrow or blood stem cells from the original kidney donor are available. For those who received their new organ through the deceased donor waitlist, we can use the donor’s bone marrow cells if they were stored at the time of the original transplant surgery. For recipients who received their new organ through living donation, the delayed tolerance treatment is available anytime as long as their original living donor is willing and medically cleared to provide bone marrow or blood stem cells.
By completing the e-questionnaire, cctt.mghlivingdonors.org, we can start the process to determine a patient's eligibility for either the simultaneous tolerance or the delayed tolerance protocols.
Simultaneous Living Donor Transplant Tolerance Program Roadmap
- Once a living donor has been approved, the recipient is prepared for kidney transplantation..
- The recipient is admitted 1 week before transplant to start medication and thymus irradiation to prepare for transplantation.
- An infusion of donor bone marrow or blood stem cells is combined with kidney transplantation to induce transplant tolerance.
- Donor bone marrow or blood stem cells will expand in the recipient body for weeks to months after transplantation and then slowly disappear.
- The recipient is on immunosuppressants to prevent rejection of the transplanted kidney.
- Biopsy of the transplanted kidney and blood tests performed 6 months post-transplant to monitor for rejection.
- Following a normal biopsy, gradual reduction of immunosuppressive medication begins and is completed 1 year after transplantation.
Delayed Tolerance Program Roadmap
- After your transplant, you’ll work with the transplant team to create an action plan for your ongoing care.
- The recipient is admitted 1 week before transplant to start medication and thymus irradiation to prepare for transplantation.
- An infusion of donor bone marrow or blood stem cells is given to induce transplant tolerance.
- The recipient is on immunosuppressants to prevent rejection of the transplanted kidney.
- Biopsy of the transplanted kidney and blood tests performed 6 months posttransplant to monitor for rejection.
- Following a normal biopsy, gradual reduction of immunosuppressive medication begins and is completed 1 year after transplantation.
Transplant conditions and treatments
Contact the Center for Clinical Tolerance
877-644-2860
International Patient Services
Contact information for international patients